Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.07%
1,101.37
-0.81
-0.07%
—1,102.181,096.241,103.051,090.35——
SIXC
Communications
SIXC
Communications
SIXC
-0.47%
613.35
-2.89
-0.47%
—616.24616.24617.68609.10——
SIXE
Energy
SIXE
Energy
SIXE
+0.77%
1,198.83
+9.11
+0.77%
—1,189.721,194.741,202.791,188.58——
SIXI
Industrials
SIXI
Industrials
SIXI
+1.75%
1,755.95
+30.26
+1.75%
—1,725.691,730.021,762.991,730.02——
SIXM
Financials
SIXM
Financials
SIXM
-0.79%
638.51
-5.11
-0.79%
—643.62643.13643.17632.59——
SIXR
Staples
SIXR
Staples
SIXR
+1.65%
843.52
+13.73
+1.65%
—829.79832.32845.25832.32——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.19%
215.95
+2.55
+1.19%
—213.40213.40216.07213.40——
SIXT
Technology
SIXT
Technology
SIXT
-1.48%
3,138.91
-47.01
-1.48%
—3,185.923,160.893,178.723,102.60——
SIXU
Utilities
SIXU
Utilities
SIXU
+2.80%
934.37
+25.43
+2.80%
—908.94912.57934.91912.57——
SIXV
Health care
SIXV
Health care
SIXV
-0.10%
1,477.43
-1.53
-0.10%
—1,478.961,478.171,482.911,466.65——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1.05%
2,380.19
-25.17
-1.05%
—2,405.362,390.342,402.532,359.18——
EVT:FRA
Evotec SE
€5.34
-4.13%
(-0.23) 1D
Apr 24, 8:10:15 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for EVT...
Open
€5.34
High
€5.34
Low
€5.34
Mkt. cap
944.59M
Avg. vol.
8.17K
Volume
1.00K
52-wk high
€8.48
52-wk low
€4.02
EPS
-€0.58
Shares outstanding
148.72M
No. of employees
4K
News stories
From sources across the web
Profile
Evotec SE is a publicly listed drug discovery and development company headquartered in Hamburg, Germany. The company operates globally, largely through external alliances with pharmaceutical and biotechnology companies, academic institutions, patient advocacy groups, and venture capitalists. As of 31 December 2021 Evotec had a market capitalization of €7.5 billion and a pipeline of more than 130 partnered programs in discovery, pre-clinical development and clinical development. The company's 4,200+ employees work across a number of therapeutic areas including CNS/neurology, metabolic diseases, Cancer, and inflammatory and infectious diseases. It has long-term discovery alliances with Bristol Myers Squibb, Bayer, Sanofi, Boehringer Ingelheim, the CHDI Foundation, Lilly, Takeda, Sernova, and more. On 28 October 2009 the company was listed on the TecDAX index, which tracks the performance of the 30 largest German companies from the technology sector. On 24 September 2018 Evotec joined the MDAX index, following a rule change that enabled dual listing. The MDAX tracks 60 Prime Standard shares from sectors excluding technology. Wikipedia
About Evotec SE
CEO-
Employees4.47K
Founded1993
Headquarters-
SectorHealth care
Websiteevotec.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
199.98M
171.24M
163.89M
253.27M
Cost of goods sold
172.75M
162.64M
163.95M
174.81M
Cost of revenue
172.75M
162.64M
163.95M
174.81M
Research and development expenses
10.76M
8.21M
8.71M
9.83M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
47.70M
41.61M
42.31M
44.35M
Operating expense
47.04M
37.19M
43.53M
55.25M
Total operating expenses
219.79M
199.83M
207.48M
230.06M
Operating income
-19.82M
-28.60M
-43.59M
23.21M
Other non operating income
-6.86M
-10.64M
1.19M
-33.96M
EBT including unusual items
-29.85M
-43.42M
-42.96M
29.46M
EBT excluding unusual items
-29.66M
-44.67M
-43.36M
18.35M
Income tax expense
1.73M
59.00K
127.00K
14.84M
Effective tax rate
-5.78%
-0.14%
-0.30%
50.37%
Other operating expenses
-11.41M
-12.63M
-7.50M
1.07M
Net income
-31.58M
-43.48M
-43.09M
14.62M
Net profit margin
-15.79%
-25.39%
-26.29%
5.77%
Earnings per share
-
-
-0.24
-
Interest and investment income
-
1.21M
841.00K
11.84M
Interest expense
-2.41M
-6.00M
-2.28M
-
Net interest expenses
-2.41M
-4.79M
-1.44M
11.84M
Depreciation and amortization charges
-
-
-
-
EBITDA
76.50K
-3.42M
-18.27M
41.91M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer